| BODY CONTOURING | PEER-REVIEW


FURTHER READING


■ Albergati F, Bacci PA, Lattarulo P, Curri S, Valutazione sull’attività microcircolatoria della tecnica Endermologie LPG in paziente con PEFS (1997). in: Le celluliti nel 2004, Minelli Editore, Arezzo 2004


■ Leibaschoff G. Cellulite: Treatment and clinic therapeutic approach. Am J Cosm Surg 1997


■ Taussig SJ, Batkin SJ. Bromelain, the enzyme complex of pineapple (Ananas comosus) and its clinical application. An update. Ethnopharmacol 1988; 22(2): 191–203


■ Bouskela E, Cyrino FZ, Marcelon G. Possible mechanisms for the inhibitory effect of Ruscus extract on increased microvascular permeability induced by histamine in hamster cheek pouch. J Cardiovasc Pharmacol 1994; 24: 281–85


■ Rossi AB, Vergnanini AL. Cellulite: a review. J Eur Acad Dermatol Venereol 2000; 14(4): 251–62


■ Linton MF, Fazio S. Macrophages, inflammation, and atherosclerosis. Int J Obes Relat Metab Disord 2003; 27(Suppl 3): S35–40


■ Cademartiri, Bertetti, Vescovi, Di Stasi: Comparative micromagnometric


References


1. Leibaschoff G, Goldman M, Bacci PA, Hexsel D, Angelini F. Cellulite: Pathophysiology and Treatment, first edition. New York: Taylor & Francis, 2006


2. CS Koblenzer. Psychosocial aspects of beauty: how and why to look good. Clin Dermatol 2003; 21(6):473–75


3. Bacci PA, Leibaschoff G. Las Celulitis. Buenos Aires: Panamericane, 2002


4. Binazzi M, Papini M. Aspetti clinico istomorfologici. In: La cellulite. di Ribuffo-Bartoletti, Salus eds. Roma: 1983


5. Curri SB. Liposclerosi e microcircolo. Dermoestetica, 1990; 1: 6–7


6. Bacci PA. Il lipolinfedema: riflessioni e osservazioni cliniche. Flebologia Oggi. Torino Minerva Med 1997; 2:10–21


7. Bacci PA. Le celluliti. Alberti C eds. Arezzo, 2000: 40–46.


8. Lafontan M. Adipose Tissue: What’s new? Kosmerische Medzin 2008; 29(5)


9. Phillips KA, Hollander E, Rasmussen SA, Aronowitz BR, DeCaria C, Goodman WK. A severity rating scale for body dysmorphic disorder: development, reliability, and validity of a modified version of the Yale-Brown Obsessive Compulsive Scale. Psychopharmacol Bull 1997; 33(1): 17–22


10. Carratelli M, Porcaro R, Ruscica M, De Simone E, Bertelli AA, Corsi MM. Reactive oxygen metabolites (ROMs) and prooxidant status in children with down syndrome. Int J Clin Pharmacol Res 2001; XXI(2):79–84


11. Belcaro G, Caratelli M, Terranova R, et al. A simple test to monitor oxidative stress. Int Angiol 1999; 18(2):127–130


12. Ceccarelli M. Cellulite: approccio diagnostico e terapeutico. Atti 1° Congr Multid Chir Plast e Invecch. Roma 9–12 November 1989


13. Smalls LK, Lee CY, Whitestone J, Kitzmiller WJ, Wickett RR, Visscher MO. Quantitative model of cellulite: three-dimensional skin surface topography, biophysical characterization, and relationship to human perception. J Cosmet Sci 2005; 56(2): 105–20


14. Bollinger A, Fagrell B. In: Clinical Capillaroscopy. Bollinger A, Fagrell B, eds. Hogrefe & Huber Publishers; 1991.


15. Angelini F, Orlandi C, Di Fiore P, et al. Medical Therapy. In: Goldman M, Hexsel D, Eds. Cellulite: Pathophysiology and Treatment, second edition. New York: Taylor & Francis, 2010


16. H Sampson. Update on food allergy. J Allergy Clin Immunol 2004; 113(5): 805–19


17. FD Finkelman. J Allergy Clin Immunol 2007; 120(3): 506–15


18. Leibaschoff GH, Coll L, Desimone JG. Non-invasive assessment of the effectiveness of Cellasene in patients with oedematous fibrosclerotic panniculopathy (cellulitis): a double-blind prospective study. Int J Cosmet Surg Aesthet Dermatol 2001; 3(4): 265–273


19. Vassallo C. Berardesca E. Efficacy of a Multifunctional plant Complex in the treatment of a localised fat-lobular Hypertrophy. American Journal of Cosmetic Surgery 2001; 18(4): 203–208


20. Erdelmeier CA, Cinatl J Jr, Rabenau H,


Doerr HW, Biber A, Koch E. Antiviral and antiphlogistic activities of Hamamelis virginiana bark. Planta Med. 1996; 62(3): 241–5


21. Smith WA, Fry AC, Tschume LC, Bloomer RJ. Effect of glycine propionyl-L-carnitine on aerobic and anaerobic exercise performance. Int J Sport Nutr Exerc Metab 2008; 18(1): 19–36


22. Lafontan M, Moro C, Berlan M, Crampes F, Sengenes C, Galitzky J. Control of lipolysis by natriuretic peptide and cyclic GMP. Trends Endocrinol Metab 2008; 19(4): 130–7


23. Lafontan M, Moro C, Sengenes C, Galitzky J, Crampes F, Berlan M. An Unsuspected Metabolic Role for Atrial Natriuretic Peptides: The Control of Lipolysis, Lipid Mobilization, and Systemic Nonesterified Fatty Acids Levels in Humans. Arterioscler Thromb Vasc Biol 2005; 25: 2032–2042


24. Lafontan M, Sengenes C, Galitzky J et al. Recent developments on lipolysis regulation in humans and discovery of a new lipolytic pathway. International Journal of Obesity 2000; 24(4): 47–52


25. Glaser R, Wurtzbacher D, Dimitrakakis C. Efficacy of testosterone therapy delivered by pellet implant. Maturitas 2009; 63(Suppl 1): 283


26. Glaser R, Kalantaridouc S, Dimitrakakis C. Testosterone implants in women: Pharmacological dosing for a physiologic effect. Maturitas 2012


27. Worboys S, Kotsopoulos D, Teede H, McGrath BP, Davis SR. Subcutaneous testosterone implant therapy improves


endothelium-dependent and independent vasodilation in postmenopausal women already receiving ooestrogen. Heart, Lung and Circulation 2000; 9(3): 109


28. Notelovitz M, Johnston M, Smith S, Kitchens C. Metabolic and hormonal effects of 25-mg and 50-mg 17beta-estradiol implants in surgically menopausal women. Obstet Gynecol 1987; 70(5); 749–54


29. Leduc A. Le drainage lymphatique. Theorie et pratique. Paris: Ed Masson, 1980


30. Foeldi M. Symposium ueber die sogenannie Zellulitis. Fellberg: 1–2 June 1983


31. Gondinet A. Tissue regeneration. European Biopharmaceutical Review 2008; 61–66


32. Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR. Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 85(6): 638–46


33. Pierce GF, Mustoe TA, Altrock BW, Deuel TF, Thomason A. Role of platelet derived growth factor in wound healing. J Cell Biochem 1991; 45(4): 319–26


34. Pistor M. Un defi therapeutique. third edition. Maloine, 1979


35. Dalloz-Bourguignon A. La mesotherapie. Maloine, 1988


36. Savin E, Bailliart O, Bonin P et al. Vasomotor effects of transcutaneous CO2 in Stage II peripheral occlusive arterial disease. Angiology 1995; 46(9): 786–91


37. Hartman BR, Bassenge E, Pittier M. Effect of Carbon Dioxide enriched water on the cutaneous microcirculation and oxygen tension in the skin of the foot. Angiology 1997; 48(11): 957–63


38. Brandi, D’aniello, Grimaldi I et al. Carbon dioxide therapy in the treatment of localized adiposities: clinical study and histopathological correlations. Aesthetic Plast Surg 2001; 25(3): 170–4


39. Bacci PA, Il ruolo della metodologia “Endermologie®”. In: Le celluliti nel 2004. Minelli Editore. Arezzo, 2004


40.Adcock D, Paulsen S, Davis S, Nanney L, Shack RB. Analysis of the cutaneous and systemic effects of Endermologie in the porcine model, Aesthet Surg J 1998; 18(6): 414–20


41. Fodor PB, Watson J, Shaw W et al. Physiological effects of Endermologie: a preliminary report, Aesthetic Surgery Journal 1999; 19 (1):1–7


42. P Fournier. Liposculpture: Ma technique. Paris: Arnette, 1989


43. A Goldman, Schavelzon DE, Blugerman GS. Laserlipolysis liposuction using Nd:YAG Laser. Rev Soc Bras Cir Plast 2002; 17: 17–26


44. Leibaschoff et al. A double-blind, prospective, clinical, 28. surgical, histopathological and ultrasound study comparing the effectiveness and safety of liposuction performed using Laserlipolysis and Internal Ultrasound Lipoplasty method, and assessing the evolution in patients. 25th Annual Meeting of the American Academy of Cosmetic Surgery, Phoenix Arizona, 2009


prime-journal.com | January/February 2015 ❚


observations on dermal and subcutaneous values during mesotherapy for localized hydrolipodystrophy, ‘medicated mesotherapy versus simulated mesotherapy’. Giornale di Mesoterapia 1983,III ,I, Salus Ed.


■ Casley–Smith JR. Lymph and lymphatic. In: Microcirculation. Kaley G, Altura BM eds. Vol I. Baltimore, Maryland: University Park Press, 1977; 423–508


■ Foldi M. Therapy of secondary lymphoedema. Med Welt 1977; 28(41): 669–1670


■ Leduc A. Il drenaggio linfatico. Milan: Masson Italia editore, 1982


■ Ball P, Knuppen R, Haupt M, Breuer H. Interactions between oestrogens and cathecolamines, J Clin Endocr 1972; 34: 736


■ Brunzel J., insulin and adipous tissue, International Journal of obesity,1981


■ Vague, J., Bjorntorp P., Metabolic complications of human obesities, Ph. Vague Eds., Excerpta Med., Amsterdam, 1985.


■ Campisi C. Il linfedema, aspetti attuali di diagnosi e terapia, Flebologia Oggi. Min Medica 1997; 1: 27–41


■ Fodor PB. Endermologie (LPG): does it work? Aesthetic


Plast Surg 1997; 21(2): 68


■ Allegra C, Pollari G, Antonini V, Curri SB, Pannicolopatia edematofibrosclerotica, Minerva. Mesoterapica 1986; 1: 12–17


■ Piérard GE, Nizet JL, Piérard-Franchimont C. Cellulite. Am J Dermatopathol 2000; 22(1): 34–7


■ Curri SB. Aspect morphohistochimiques du tissue adipeux dans la dermohypodermose cellulitique. J Med Est 1976; 5: 183


■ Merlen JF. La part de la cellulite dans la douleurs vasculaires. Angiologie 1966; 3: 21–24


■ Bacci PA, Allegra C, Albergati F, Brambilla E, Botta G, Mancini S. Randomized, placebo controlled double blind clinical study on efficacy of a multifunctional plant complex in the treatment of the so called cellulites. J Aesthet Surg Dermatol Surg 2003; 5(1): 53


■ Bacci PA, Allegra C, Mancini S. Valutazione clinica controllata in doppio cieco di prodotti fitocomposti nel trattamento della cosiddetta cellulite. In: Bacci PA, Mariani S. La flebologia in pratica. Alberti & C. Ed. Arezzo Italy, 2003


■ Bilancini S, Lucchi M. Proposition de classification


des grosses jambes. Plebologie 1989; 42(1): 151–156


■ Bilancini S, Lucchi M, Approccio al lipedema. Linfologia 1989; 1: 24–26


■ Bilancini S, Lucchi M, Tucci S, El lipedema: criterios clinicos y diagnosticos. Angiologia 1990; 4(90); 133–137


■ Bacci P.A., La cellulite da scoprire. In: Alberti C eds. Arezzo 2003


■ Albergati FG, Bacci PA. La matrice extracellulare. Arezzo Italy: Minelli Editore, 2004


■ LS Toledo. Superficial Syringe Liposculpture for cellulite treatment. Plastic Surgery Symposium, Beverly Hills, California; 23–25th June 1990


■ Karen K, Geronemus R. Laser lipolysis using a novel 1,064nm Nd:YAG laser. Dermatolo Surg 2006; 32: 241–48


■ Angelini F. Medical therapy. In: Cellulite Pathophysiology and treatment, second edition. Goldman MP, Hexsel D eds. New york: Informa Healthcare, 2010


■ Lafontan M, Moro C. Natriuretic peptide and GMP signaling control energy homeostasis. Am J Physiol Heart Circ Physiol 2013; 304(3): 358–68


49


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64